Masanori Abe

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Teru Kumagi · 4 shared papers, 2013–2020 · strength 0.24
   • Paper Familial Pancreatic Cancer at Elderly Siblings in Japan. DOI 10.5005/jp-journals-10018-1296↗
   • Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
   • Paper Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer. DOI 10.1371/journal.pone.0071367↗
2. Nobuaki Azemoto · 3 shared papers, 2013–2020 · strength 0.15
   • Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
   • Paper Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer. DOI 10.1371/journal.pone.0071367↗
   • Paper Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collabo… DOI 10.1186/1471-230x-13-134↗
3. Mitsuhito Koizumi · 3 shared papers, 2013–2020 · strength 0.15
   • Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
   • Paper Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer. DOI 10.1371/journal.pone.0071367↗
   • Paper Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collabo… DOI 10.1186/1471-230x-13-134↗
4. Yoichi Hiasa · 3 shared papers, 2013–2020 · strength 0.15
   • Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
   • Paper Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer. DOI 10.1371/journal.pone.0071367↗
   • Paper Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collabo… DOI 10.1186/1471-230x-13-134↗
5. Yoshinori Ohno · 2 shared papers, 2013–2020 · strength 0.11
   • Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
   • Paper Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collabo… DOI 10.1186/1471-230x-13-134↗
6. Yoshinori Tanaka · 2 shared papers, 2013–2020 · strength 0.11
   • Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
   • Paper Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collabo… DOI 10.1186/1471-230x-13-134↗
7. Taira Kuroda · 2 shared papers, 2013–2020 · strength 0.11
   • Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
   • Paper Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collabo… DOI 10.1186/1471-230x-13-134↗
8. Takashi Terao · 1 shared paper, 2020 · strength 0.08
   • Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
9. Hiroshi Ishii · 1 shared paper, 2020 · strength 0.08
   • Paper ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. DOI 10.2169/internalmedicine.3748-19↗
10. Morikazu Onji · 2 shared papers, 2013 · strength 0.06
    • Paper Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer. DOI 10.1371/journal.pone.0071367↗
    • Paper Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collabo… DOI 10.1186/1471-230x-13-134↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.